human dihydropyrimidinase-like 2,DPYSL2 ELISA Kit
- Known as:
- H. sapiens dihydropyrimidinase-like 2,DPYSL2 Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- SL0618Hu
- Product Quantity:
- 48T
- Category:
- -
- Supplier:
- Sunlong
- Gene target:
- human dihydropyrimidinase-like 2 DPYSL2 ELISA Kit
Ask about this productRelated genes to: human dihydropyrimidinase-like 2,DPYSL2 ELISA Kit
- Gene:
- DPYSL2 NIH gene
- Name:
- dihydropyrimidinase like 2
- Previous symbol:
- -
- Synonyms:
- DRP-2, DHPRP2, CRMP2, DRP2
- Chromosome:
- 8p21.2
- Locus Type:
- gene with protein product
- Date approved:
- 1997-02-27
- Date modifiied:
- 2016-10-05
Related products to: human dihydropyrimidinase-like 2,DPYSL2 ELISA Kit
Related articles to: human dihydropyrimidinase-like 2,DPYSL2 ELISA Kit
- The prevalence of atrial fibrillation (AF) is increasing due to the aging population. Mitophagy is crucial for maintaining cardiomyocyte function, while ion channels play a key role in cardiac electrical activity. Dysfunction of ion channels can trigger AF. However, the role of mitophagy-related ion channel genes in AF remains unclear. - Source: PubMed
Publication date: 2025/11/20
Wu XizeYan XiaoruiMa RuoxiWu QiuyingPan XueWu QihuaRen JiaqiHuang YuxiGao ShanLi YueGong Lihong - The molecular processes involved in the progression of neuropsychiatric and liver disorders in some patients who have achieved sustained virologic response after successful DAA treatment are still unclear. To understand these processes, we investigated alterations in the transcription patterns of genes associated with neural and immune functions after DAA therapy. - Source: PubMed
Publication date: 2025/11/16
Ghobadi Mohadeseh ZareiEsfehani Mohammad Amin NooraniyanShahmahmoodi ShohrehNejati AhmadKeshavarz AbolfazlSamimi-Rad Katayoun - To discover therapeutic targets and biomarkers for ischemic stroke, a systems-level understanding of the altered brain proteome is necessary from various types of in vivo models. In the last two decades, despite accumulating numerous large-scale proteomics datasets on in vivo models of ischemic stroke, systematic classification and summarization of these data have not been attempted yet. - Source: PubMed
Publication date: 2025/11/07
Gogoi AnaekshiBabu ManjuGangadhar AbhinaShirin RiyamaThomas Deepthi AnnJayaram JasmithaThakkar PratikDatta Arnab - Thoracic aortic aneurysms frequently go undetected until serious complications like acute dissections or ruptures arise. Therefore, this study aims to identify potential blood circulating biomarkers enabling an easy and early diagnosis of thoracic aortic disease. - Source: PubMed
Publication date: 2025/10/07
Arndt NicoMair ThomasRiedner MariaBiabani AliVoß HannahSchlüter HartmutFörster LukasKnochenhauer TimSachse MarcoBeyer MartinLeonhardt Mayavon Kodolitsch YskertSchlein ChristianSauter GuidoNauth TheresaNaito ShihoGirdauskas EvaldasReichenspurner HermannDetter ChristianRosenberger GeorgDemal Till Joscha - Chronic venous disease (CVD) is a prevalent vascular disorder with a poorly characterized genetic basis. In this study, we employed an integrative omics strategy combining genome-wide association studies (GWAS), expression quantitative trait loci (eQTL) mapping, endothelial cell functional assays, and transcriptomic correlation analysis to elucidate the molecular architecture of CVD. A GWAS conducted in a Taiwanese population identified two CVD-associated single nucleotide polymorphisms: VSTM2L rs1998049 and DPYSL2 rs1442887. Through eQTL analysis and endothelial functional assays, four QTLs (VSTM2L, RPRD1B, SAMHD1, and PNMA2) were found to significantly affect VEGF consumption, vWF expression, and endothelial tube formation. Co-expression and correlation analyses further linked these QTLs to key vascular effector genes, including VEGF, vWF, MMP9, and CCM2. A logistic regression model based on QTL expression profiles demonstrated high diagnostic performance (area under the curve, AUC = 0.898), highlighting their translational potential. These findings offer novel insights into the functional genomics of CVD, particularly in relation to vascular remodeling, endothelial dysfunction, and inflammation. They also demonstrate the utility of multi-omics integration for biomarker discovery in complex vascular disorders. - Source: PubMed
Publication date: 2025/08/29
Chuang Cheng-HsunHuang Hsiao-HsuanWu Yi-SyuanHo Nien-CheHuang Chi-TingHuang Yi-ChenHuang Hsien-DaWeng Shun-LongLee Meng-LinLiao Kuang-Wen